Tue, June 21, 2022
Sun, June 19, 2022
Fri, June 17, 2022
Thu, June 16, 2022
Wed, June 15, 2022
Tue, June 14, 2022
Mon, June 13, 2022
Sun, June 12, 2022
Fri, June 10, 2022
Thu, June 9, 2022
Wed, June 8, 2022

Ashwani Verma Initiated (TEVA) at Hold and Held Target at $10 on, Jun 14th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-10-on-jun-14th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ashwani Verma of UBS, Initiated "Teva Pharmaceutical Industries Limited" (TEVA) at Hold and Held Target at $10 on, Jun 14th, 2022.

Ashwani has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Ashwani's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Upgraded from Sell to Hold and Held Target at $9 on, Tuesday, May 17th, 2022
  • Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $9 on, Thursday, May 12th, 2022


These are the ratings of the 2 analyists that currently disagree with Ashwani


  • David Amsellem of "Piper Sandler" Downgraded from Hold to Sell and Decreased Target to $7 on, Wednesday, May 4th, 2022
  • Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022

Publication Contributing Sources